UTA researchers take advantage of biochemistry technique to identify rare radioactive decays

UTA researchers are leading an international team developing a new device that could enable physicists to take the next step toward a greater understanding of the neutrino, a subatomic particle that may offer an answer to the lingering mystery of the universe's matter-antimatter imbalance.

Physics tells us that matter is created side by side with antimatter. But if matter and antimatter are produced equally, then all of the matter created in the early universe should have been canceled out by equal amounts of antimatter, eliminating existence itself instantly. And we would not exist.

To explain this asymmetry, some particle physicists claim that the tiny subatomic particle, the neutrino, and its antimatter particle, the antineutrino, are in fact the same particle. This might account for the overall excess of matter in the universe as a whole-- and why we are here.

UTA researchers are now taking advantage of a biochemistry technique that uses fluorescence to detect ions to identify the product of a radioactive decay called neutrinoless double-beta decay that would demonstrate that the neutrino is its own antiparticle.

Radioactive decay is the breakdown of an atomic nucleus releasing energy and matter from the nucleus. Ordinary double-beta decay is an unusual mode of radioactivity in which a nucleus emits two electrons and two antineutrinos at the same time. However, if neutrinos and antineutrinos are identical, then the two antineutrinos can, in effect, cancel each other, resulting in a neutrinoless decay, with all of the energy given to the two electrons.

To find this neutrinoless double-beta decay, scientists are looking at a very rare event that occurs about once a year, when a xenon atom decays and converts to barium. If a neutrinoless double-beta decay has occurred, you would expect to find a barium ion in coincidence with two electrons of the right total energy. UTA researchers' proposed new detector precisely would permit identifying this single barium ion accompanying pairs of electrons created within large quantities of xenon gas.

"If we observe even one such event, it would be a profound discovery in particle physics, on par with the discovery of the Higgs boson," said Ben Jones, UTA assistant professor of physics, who is leading this research for the American branch of the Neutrino Experiment with Xenon TPC - Time Projection Chamber or NEXT program, which searches for neutrinoless double-beta decay. Other UTA researchers also collaborated on the ATLAS experiment, which led to the Nobel Prize winning discovery of the Higgs boson in 2012.

The researchers, who published their discovery Monday in Physical Review Letters, have demonstrated the effectiveness of their technique on a small scale and now plan to use the device in a large-scale detector, which they envision as a chamber containing a ton of high-pressure, purified xenon gas.

David Nygren, UTA Presidential Distinguished Professor of Physics and a member of the National Academy of Sciences, had the idea to look at fluorescence when he realized how neuroscientists use the technique to look at calcium ions that jump from neuron to neuron in the brain.

"I realized that calcium and barium are not so different, so perhaps we could use the same technique to search for neutrinoless double-beta decay," Nygren said.

Early research with UTA graduate student Austin McDonald identified a chemical compound called FLUO-3 that not only works with calcium ions but is also sensitive to barium. From there, the team devised a device that could reveal barium ions in a large volume of gaseous xenon, which was proven in the published paper.

"The beauty of this research is that it brings together physicists and chemists in generating creative new solutions to enable discoveries in fundamental physics," said UTA physics chair Alex Weiss. "This work clearly demonstrates the ability of students and faculty at UTA to lead the way in international physics projects and represents an important example of the world-class research enabled by UTA's focus on data-driven discovery."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals how tumor cells evade the immune system